Growth Metrics

Iradimed (IRMD) Change in Account Payables (2016 - 2026)

Iradimed has reported Change in Account Payables over the past 14 years, most recently at $362000.0 for Q1 2026.

  • Quarterly Change in Account Payables fell 47.84% to $362000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$408000.0 through Mar 2026, down 186.38% year-over-year, with the annual reading at -$76000.0 for FY2025, 91.18% up from the prior year.
  • Change in Account Payables was $362000.0 for Q1 2026 at Iradimed, up from -$513069.0 in the prior quarter.
  • Over five years, Change in Account Payables peaked at $1.6 million in Q2 2023 and troughed at -$1.2 million in Q3 2023.
  • The 5-year median for Change in Account Payables is $52960.0 (2022), against an average of $19560.9.
  • The largest YoY upside for Change in Account Payables was 2190.24% in 2022 against a maximum downside of 6104.67% in 2022.
  • A 5-year view of Change in Account Payables shows it stood at $1.1 million in 2022, then tumbled by 167.68% to -$736084.0 in 2023, then surged by 47.26% to -$388180.0 in 2024, then tumbled by 32.17% to -$513069.0 in 2025, then skyrocketed by 170.56% to $362000.0 in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Change in Account Payables are $362000.0 (Q1 2026), -$513069.0 (Q4 2025), and $432494.0 (Q3 2025).